To ask His Majesty's Government what assessment they have made of the quality and consistency of triple negative breast cancer data collected in England; and what steps they are taking to improve it.
Answered on
19 September 2024
Data on triple negative breast cancer for England is collected through the National Disease Registration Service (NDRS). An NDRS Quality Assurance Team is in place to identify, investigate, and monitor data quality issues, with over 130 Quality Assurance reports being run each month as well as quarterly reports to assess the completeness of key data.
To drive up the completeness of the data for triple negative breast cancer, progesterone receptor status, human epidermal growth factor receptor in situ hybridization status, and oestrogen receptor status are part of the Cancer Outcomes and Services Data set, which supports national registration.